Therapeutic Potentials of Acarbose as First-Line Drug in NIDDM Insufficiently Treated With Diet Alone
Year: 1991
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Care
Authors: Markolf Hanefeld, Sabine Fischer, Jan Schulze, Manfred Spengler, Manfred Wargenau, Karl Schollberg, Katja Fücker
Institutions: University Hospital Carl Gustav Carus, Nagoya University
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: acarbose, type 2 diabetes, alpha-glucosidase inhibitors, postprandial hyperglycemia, fasting blood glucose, HbA1c, postprandial insulin, triglycerides, gastrointestinal adverse effects, flatulence, drug acceptability, dietary therapy, first-line therapy, drug efficacy, drug safety, cost-effectiveness, cost-benefit analysis
Open Access status: closed
OpenAlex ID: W1954810
